Evidence map›Paper›PMID 36943878›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea.

Wentao Liang, Li Huang, Amy Whelchel, Tian Yuan, Xiang Ma, Rui Cheng, Yusuke Takahashi, Dimitrios Karamichos, Jian-Xing Ma

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fenofibrate microemulsion eyedrops for treating nitrogen mustard induced corneal injury.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  5. Article
  6. Article
  7. Ferroptosis: A Novel Mechanism in Diabetic Keratopathy.Investigative ophthalmology & visual science · 2026
    Article
  8. Article
  9. Diabetic keratopathy and nuclear proteins (Review).Molecular medicine reports · 2026
    Review
  10. Fenofibrate in ophthalmology: therapeutic efficacy and mechanisms.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Wentao LiangDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-0609-6280
Li HuangDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157.ORCID 0000-0003-3957-0513
Amy WhelchelDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Tian YuanDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Xiang MaDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Rui ChengDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157.ORCID 0000-0002-6634-5699
Yusuke TakahashiDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Dimitrios KaramichosDivision of Research and Innovation, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107.ORCID 0000-0002-8761-3824
Jian-Xing MaDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Wake Forest University · USFujian Medical University · CNUniversity of North Texas · USUniversity of Oklahoma Health Sciences Center · US

Funding

A new pathogenic mechanism for diabetic retinopathyR01EY019309 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jian-Xing Jay Ma · 2009 to 2026
$6.1M
STUDIES OF RPE65R01EY012231 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, JIAN-XING, MOISEYEV, GENNADIY · 1998 to 2021
$5.7M
Sustained release of fenofibrate for the treatment of diabetic retinopathyR01EY033477 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jian-Xing Jay Ma, QINGGUO XU · 2022 to 2026
$2.7M
A Novel Pathogenic Pathway for Diabetic KeratopathyR01EY028949 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Dimitrios Karamichos, Jian-Xing Jay Ma · 2018 to 2026
$2.2M
cGAS-STING signaling in diabetic retinopathyR01EY033330 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jian-Xing Jay Ma, Yusuke Takahashi · 2022 to 2026
$1.9M
Dysregulation of Wnt signaling in subretinal fibrosis in AMDR01EY032931 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI TAKAHASHI, YUSUKE · 2021 to 2025
$1.9M
Studies of retinyl ester hydrolase in the visual cycleR01EY032930 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, JIAN-XING JAY, MOISEYEV, GENNADIY · 2021 to 2025
$1.9M
Choroidal Gamma Delta T Cells as Novel Regulators of RPE DegenerationR01EY028773 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CAI, JIYANG · 2018 to 2021
$1.8M
NEI NIH HHS R01 EY012231NEI NIH HHS R01 EY019309NEI NIH HHS R01 EY028773NEI NIH HHS R01 EY028949NEI NIH HHS R01 EY032930NEI NIH HHS R01 EY032931NEI NIH HHS R01 EY033330NEI NIH HHS R01 EY033477
6 · The paper itself

Abstract

Diabetes can result in impaired corneal wound healing. Mitochondrial dysfunction plays an important role in diabetic complications. However, the regulation of mitochondria function in the diabetic cornea and its impacts on wound healing remain elusive. The present study aimed to explore the molecular basis for the disturbed mitochondrial metabolism and subsequent wound healing impairment in the diabetic cornea. Seahorse analysis showed that mitochondrial oxidative phosphorylation is a major source of ATP production in human corneal epithelial cells. Live corneal biopsy punches from type 1 and type 2 diabetic mouse models showed impaired mitochondrial functions, correlating with impaired corneal wound healing, compared to nondiabetic controls. To approach the molecular basis for the impaired mitochondrial function, we found that Peroxisome Proliferator-Activated Receptor-α (PPARα) expression was downregulated in diabetic human corneas. Even without diabetes, global

Indexed as

Diabetes Mellitus, ExperimentalPPAR alphaAnimalsCorneaHumansMiceMice, KnockoutMitochondriaWound HealingPPAR alphacorneaepitheliummitochondriaPPARαwound healing

Identifiers

PMID36943878
PMCPMC10068757
OpenAlexW4328047994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.